Arrowhead Pharmaceuticals (ARWR) Enterprise Value: 8.834B

Arrowhead Pharmaceuticals, Inc. (ARWR)

64.19 -0.60 (-0.93%) USD | NASDAQ | Oct 02, 16:00

64.06 -0.13 (-0.20%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1999. Start Trial.

Date	Value
October 02, 2026	8.834B
October 01, 2026	8.919B
September 30, 2026	9.012B
September 29, 2026	9.125B
September 28, 2026	9.013B
September 25, 2026	9.078B
September 24, 2026	9.100B
September 23, 2026	9.225B
September 22, 2026	9.917B
September 21, 2026	9.483B
September 18, 2026	9.157B
September 17, 2026	9.335B
September 16, 2026	9.060B
September 15, 2026	9.749B
September 14, 2026	11.16B
September 11, 2026	11.47B
September 10, 2026	11.46B
September 09, 2026	11.44B
September 08, 2026	11.79B
September 04, 2026	11.96B
September 03, 2026	11.98B
September 02, 2026	11.82B
September 01, 2026	11.45B
August 31, 2026	11.40B
August 28, 2026	11.76B

Date	Value
August 27, 2026	12.28B
August 26, 2026	12.35B
August 25, 2026	12.32B
August 24, 2026	12.02B
August 21, 2026	12.07B
August 20, 2026	12.12B
August 19, 2026	12.39B
August 18, 2026	12.18B
August 17, 2026	12.29B
August 14, 2026	12.00B
August 13, 2026	11.85B
August 12, 2026	12.09B
August 11, 2026	12.37B
August 10, 2026	12.24B
August 07, 2026	12.15B
August 06, 2026	11.89B
August 05, 2026	12.04B
August 04, 2026	12.42B
August 03, 2026	11.91B
July 31, 2026	11.72B
July 30, 2026	12.10B
July 29, 2026	11.94B
July 28, 2026	11.88B
July 27, 2026	11.85B
July 24, 2026	11.86B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks